According to a meta-analysis by Wang J. et al., which included 25 eligible studies comprising 7921 participants with chronic kidney disease (CKD), statin therapy was significantly associated with a reduction in CRP levels (mean difference: −2.06 mg/L) [115]. The gene discussed is CRP; the disease is chronic kidney disease.